Essent Group Ltd. ESNT 深 滬
已收盤 02-06 16:00:00 美东时间
65.28
+0.050
+0.08%
華盛通- 最 高66.36
- 今 開65.49
- 成交量 85.92万股
- 最 低 65.225
- 昨 收 65.23
- 總市值 63.10亿
- 52周最高 67.09
- 市盈率 靜 9.54
- 換手率 0.89%
- 52周最低 50.68
- 委 比 0.00%
- 總股本 9666.51万
- 歷史最高 67.09
- 量 比 1.39
- 振 幅 1.74%
- 歷史最低 10.625
- 每 手 1
- 風險率 3.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Essent Group Ltd. Schedules Fourth Quarter Earnings Conference Call for February 13, 2026
Essent Group Ltd. will hold a conference call on February 13, 2026, at 10:00 a.m. ET to discuss its fourth quarter 2025 results, which will be announced before the market opens. The call will be available live via webcast or by phone (888-330-2384 for U.S., 240-789-2701 for international, passcode 9824537). A replay will be accessible online for one year and via phone for two weeks. Additional financial information is available on Essent’s websit...
01-23 11:30
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
JP Morgan Maintains Neutral on Essent Group, Raises Price Target to $66
JP Morgan analyst Richard Shane maintains Essent Group (NYSE:ESNT) with a Neutral and raises the price target from $65 to $66.
01-13 01:55
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
美股大行评级 | 杰富瑞上调百度目标价从159美元升至181美元；花旗下调京东目标价从44美元下调至37美元
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从47美元升至48美元；BTIG：维持Hudson Pacific Properties"买入"评级，目标价从4.75美元升至26美元
01-05 13:52
Roth Capital Maintains Buy on Essent Group, Raises Price Target to $75
Roth Capital analyst Harry Fong maintains Essent Group (NYSE:ESNT) with a Buy and raises the price target from $70 to $75.
01-03 01:33
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
Keefe, Bruyette & Woods Maintains Market Perform on Essent Group, Raises Price Target to $73
Keefe, Bruyette & Woods analyst Bose George maintains Essent Group (NYSE:ESNT) with a Market Perform and raises the price target from $71 to $73.
2025-12-18 21:55
Essent Group shares are trading lower after the company reported worse-than-expected Q3 financial results.
Essent Group shares are trading lower after the company reported worse-than-exp...
2025-11-07 21:43
